MRX-34

N/A

Report date: 2024/09/14 11:13:45
NME

Base Information

Drug NameMRX-34
Drug Alias NamemiR-34 (Synlogic)miR-34 mimic (Synlogic)MRX-34MRX-01
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionmicroRNA-34a stimulants
TargetsmicroRNA-34a
Therapy Area/IndicationsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell LungLiver Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSynlogic Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMirna Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell LungLiver Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A